Celebrate International Women's Day with Biointron's female workforce!
Biointron is excited to announce our newly launched CHOK1-Fut8KO expression platform for afucosylated antibodies.
On March 21st, Biointron Biological Shanghai R&D Center welcomed AstraZeneca delegations Mark Cobbold, Margie Li, Hao Huang, and Yingjie Wu for an on-site visit.
Founded in 2012 and certified to ISO 9001:2015, Biointron is a CRO specializing in antibody discovery, expression, and optimization services for biotech and pharmaceutical companies.
ScientistとScience Exchangeとのご利用可能です。